392
On 8/05/2008, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 541. The active ingredient is [Nle4, D-Phe7″>-alpha-melanocyte stimulating hormone for treatment of erythropoietic protoporphyria.